These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26166260)

  • 21. The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.
    Juhász MLW; Levin MK; Marmur ES
    Dermatol Surg; 2017 Jun; 43(6):841-847. PubMed ID: 28498207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent inflammatory reaction to hyaluronic acid gel: a case report.
    Bisaccia E; Lugo A; Torres O; Johnson B; Scarborough D
    Cutis; 2007 May; 79(5):388-9. PubMed ID: 17569402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed-onset complications of facial soft tissue augmentation with permanent fillers in 85 patients.
    Kadouch JA; Kadouch DJ; Fortuin S; van Rozelaar L; Karim RB; Hoekzema R
    Dermatol Surg; 2013 Oct; 39(10):1474-85. PubMed ID: 24090257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of effect by injection volume and facial subregion for a volumizing hyaluronic acid filler in treating midface volume deficit.
    Glaser DA; Kenkel JM; Paradkar-Mitragotri D; Murphy DK; Romagnano L; Drinkwater A
    Dermatol Surg; 2015 Aug; 41(8):942-9. PubMed ID: 26218727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing inflammatory reaction to restylane.
    Soparkar CN; Patrinely JR
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):151-3. PubMed ID: 15778672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersensitivity reaction to hyaluronic acid with negative skin testing.
    Patel VJ; Bruck MC; Katz BE
    Plast Reconstr Surg; 2006 May; 117(6):92e-94e. PubMed ID: 16651928
    [No Abstract]   [Full Text] [Related]  

  • 27. Foreign body reaction to hyaluronic acid filler injection: in search of an etiology.
    Mamelak AJ; Katz TM; Goldberg LH; Graves JJ; Kaye VN; Friedman PM
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1701-3. PubMed ID: 19807767
    [No Abstract]   [Full Text] [Related]  

  • 28. Allergic reaction to hyaluronidase use after hyaluronic acid filler injection.
    Kim MS; Youn S; Na CH; Shin BS
    J Cosmet Laser Ther; 2015; 17(5):283-5. PubMed ID: 25588036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe granulomatous allergic tissue reaction after hyaluronic acid injection in the treatment of facial lines and its surgical correction.
    Hönig JF; Brink U; Korabiowska M
    J Craniofac Surg; 2003 Mar; 14(2):197-200. PubMed ID: 12621290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronidase Caveats in Treating Filler Complications.
    Landau M
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S347-53. PubMed ID: 26618463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature.
    Alijotas-Reig J; Garcia-Gimenez V
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):150-61. PubMed ID: 18211407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year retrospective review of safety, injected volumes, and longevity of the hyaluronic acid Belotero Basic for facial treatments in 317 patients.
    Kühne U; Imhof M; Kirchmeir M; Howell DJ
    J Drugs Dermatol; 2012 Sep; 11(9):1032-5. PubMed ID: 23135643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermalive Facial Filler Granulomas Masquerading as Neurofibromas.
    Wolkow N; Jakobiec FA; Yoon MK
    Ophthalmic Plast Reconstr Surg; 2018; 34(3):e99-e103. PubMed ID: 29547466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients.
    Wiest LG; Stolz W; Schroeder JA
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1681-8. PubMed ID: 19807764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips.
    Philipp-Dormston WG; Hilton S; Nathan M
    J Cosmet Dermatol; 2014 Jun; 13(2):125-34. PubMed ID: 24910276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions to injectable soft tissue fillers.
    Requena L; Requena C; Christensen L; Zimmermann US; Kutzner H; Cerroni L
    J Am Acad Dermatol; 2011 Jan; 64(1):1-34; quiz 35-6. PubMed ID: 21167403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complications associated with injectable hyaluronic acid].
    Pons-Guiraud A
    Ann Dermatol Venereol; 2012 Jan; 139(1):6-8. PubMed ID: 22225736
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement.
    Brody HJ
    Dermatol Surg; 2005 Aug; 31(8 Pt 1):893-7. PubMed ID: 16042932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature.
    Kassir R; Kolluru A; Kassir M
    J Cosmet Dermatol; 2011 Sep; 10(3):224-31. PubMed ID: 21896135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.